Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

v3.23.1
Subsequent Events (Details Narrative) - USD ($)
12 Months Ended
Mar. 29, 2023
Mar. 24, 2023
Mar. 13, 2023
Mar. 07, 2023
Jan. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Mar. 09, 2023
Jan. 31, 2022
Subsequent Event [Line Items]                  
Operating lease obligation           $ 1,614,000 $ 690,000   $ 1,200,000
Operating Lease, Payments           $ 265,000 $ 509,000    
Subsequent Event [Member]                  
Subsequent Event [Line Items]                  
Insurance policies $ 1,700,000                
Subsequent Event [Member] | Vivo Pharm [Member]                  
Subsequent Event [Line Items]                  
Equipment Expense       $ 200,000          
Operating Lease, Payments     $ 200,000            
Subsequent Event [Member] | San Diego Office And Laboratory Lease Agreement [Member]                  
Subsequent Event [Line Items]                  
Termination fee               $ 45,000  
Operating lease obligation               $ 1,200,000  
Subsequent Event [Member] | Equity Distribution Agreement [Member] | Canaccord Genuity LLC [Member]                  
Subsequent Event [Line Items]                  
Aggregate offering price   $ 20,000,000              
Subsequent Event [Member] | Purchase Agreement [Member] | Lincoln Park Capital Fund LLC [Member]                  
Subsequent Event [Line Items]                  
Aggregate offering price   $ 15,000,000              
Cash Preservation Plan [Member] | Subsequent Event [Member]                  
Subsequent Event [Line Items]                  
Termination benefits         $ 954,000